期刊文献+

环氧化酶-2特异抑制剂SC236对NF-κB活性的阻断作用 被引量:2

A specific COX-2 inhibitor SC236 suppresses NF-κB activation by inhibition of p65 nuclear translocation
原文传递
导出
摘要 目的 探讨环氧化酶 2抑制剂的抗炎和抗肿瘤作用机理。方法 利用NF κB报告基因暂时转染人胃上皮细胞 ,使用环氧化酶 2特异抑制剂SC2 36和PMA共同处理转染的细胞后 ,双重虫荧光素酶系统鉴定基因的活性。用免疫蛋白印迹法检测NF κB亚单位IκB α和p6 5的含量。结果 在人胃上皮细胞AGS和MKN2 8细胞内 ,SC2 36有效地抑制NF κB介导的基因转录。SC2 36的作用比非特异性环氧化酶抑制剂阿斯匹林更强大。SC2 36与阿斯匹林的作用点不同 ,SC2 36对PMA引起的IκB α的磷酸化或降解没有作用 ,SC2 36的作用点在于抑制p6 5亚单位的核易位。结论 环氧化酶 2特异抑制剂的抗炎和抗肿瘤作用可能部分地通过抑制NF κB发挥作用。特异的COX 2抑制剂抑制NF κB活性的作用点不同于非特异的环氧化酶抑制剂。 Objective To study the molecular mechanism of anti-inflammation and anti-tumor by specific COX-2 inhibitor. Methods Two human gastric epithelial cell lines were transiently transfected with NF-κB luciferase reporter plasmid and then treated with a specific COX-2 (Cyclooxygenase) inhibitor SC236 plus PMA. Firefly lucifease activities were measured using the Dual-Luciferase Reporter assay system. Western blot analysis was used to detect phospho-IκB-α, IκB-α, and p65 protein. Results SC236 can effectively suppress nuclear NF-κB mediated gene transcription in two human epithelial gastric cancer cell lines. The potency of SC236 is more than one magnitude higher than that of the non-specific COX inhibitor aspirin. Furthermore, it appears that SC236 acts through different mechanisms. Unlike aspirin, SC236 had no significant effect on PMA-induced IκB-α phosphorylation and degradation. Instead, SC236 works through suppressing the nuclear translocation of the NF-κB subunit, p65 protein. Conclusion Our study suggests an important molecular mechanism by which a COX-2 inhibitor can reduce inflammation and carcinogenesis in gastric epithelial cells.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2003年第10期749-752,共4页 Chinese Journal of Microbiology and Immunology
  • 相关文献

同被引文献26

  • 1吕红凯,张雁钢,王东文.COX-2在肾癌中的表达及其临床意义[J].临床医药实践,2008,17(1):13-16. 被引量:4
  • 2马中富,乐胜,梁艳冰,詹红,唐皓,荆小莉.p38丝裂原活化蛋白激酶抑制剂对脓毒症大鼠多器官损伤的保护作用研究[J].中国危重病急救医学,2005,17(4):211-213. 被引量:18
  • 3王今达.多脏器功能失常综合征与肠道内细菌及内毒素易位[J].中国危重病急救医学,1995,7(6):321-323. 被引量:92
  • 4方立,刘修恒,罗洪波.肾细胞癌中COX-2与血管生成的相关性研究[J].武汉大学学报(医学版),2006,27(2):152-155. 被引量:6
  • 5孙卫民 王惠琴.细胞因子研究方法学[M].北京:人民卫生出版社,2000.644-653.
  • 6Bone RC, Balk RA, Cerra FB, et al. The ACCP/SCCM consensus conference committee. Definition for sepsis and organ failure and guidelines for use of innovative therapies in sepsis [J]. Chest, 1992, 101 (6): 1644 -1655.
  • 7Rangel EB, Moura LA, Franco MF, et al. Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection [J]. Clin Transplant, 2005, 19 (4): 543-550.
  • 8Jiang Y, Gram H, Zhao M, et al. Characterization of the structure and function of the fourth member of p38 group mitogen-activated protein kinase, p38 delta [J]. J Biol Chem, 1997, 272 (48) : 301222-30128.
  • 9Setemes OM, Johansen B, Hegge B, et al. Both binding and activation of p38 mitogen-activated protein kinase (MAPK) play esseneial roles in regulation of the nucleocytoplasmic distribution of MAPK-activated protein kinase 5 by cellular stress [J]. Mol cell Biol, 2002, 22 (20) : 6931-6945.
  • 10Oberholzer A, Oberholzer C, Moldawer LL. Sepsis syndromes: understanding the role of innate and acquired immunity [ J ]. Shock, 2001, 16 (2): 83-96.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部